Ipca Laboratories gets VAI classification for Indore facility

31 Oct 2023 Evaluate

Ipca Laboratories has received voluntary action indicated (VAI) classification from the United States Food and Drug Administration (USFDA) for its manufacturing facility situated at SEZ Indore, Pithampur (Madhya Pradesh). USFDA inspected the company’s said manufacturing facility from June 15, 2023 to June 23, 2023. This facility is considered to be in a minimally acceptable state of compliance with regard to current good manufacturing practice (CGMP). 

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.

Ipca Laboratories Share Price

1553.75 -1.45 (-0.09%)
17-Mar-2026 15:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1792.65
Dr. Reddys Lab 1283.10
Cipla 1277.10
Zydus Lifesciences 889.35
Lupin 2295.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×